No Data
No Data
Express News | Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Spero Therapeutics: Board Grants 116,667 Restricted Stk Unit Awards to New Employee >SPRO
Spero Therapeutics: Board Grants 116,667 Restricted Stk Unit Awards to New Employee >SPRO
Press Release: Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
CAMBRIDGE, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare
Express News | HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $7 Price Target
Spero Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 316.67% HC Wainwright & Co. → $7 Reiterates Buy → Buy 04/04/2024 — Cantor Fitzgerald Reiterate
No Data